FineTest
SKU:FNab00960
anti- BRMS1 antibody
anti- BRMS1 antibody
Couldn't load pickup availability
Explore the functions of BRMS1 (Breast Cancer Metastasis Suppressor 1) with our Anti-BRMS1 Antibody, available in a 100µg size. This high-quality antibody is your versatile tool for investigating BRMS1's roles in metastasis suppression, cancer progression, and tumor microenvironment.
Engineered for precision and reliability, this antibody ensures exceptional sensitivity in applications such as western blotting, immunofluorescence, and co-immunoprecipitation. Whether you're studying BRMS1's involvement in tumor cell adhesion, motility, or its interactions with metastasis-related proteins, this antibody enhances your research capabilities.
BRMS1 is a well-known metastasis suppressor protein that plays a crucial role in inhibiting cancer cell metastasis. Understanding BRMS1's functions and its mechanisms of action is fundamental in deciphering its contributions to cancer biology and metastasis regulation.
With our Anti-BRMS1 Antibody, you can delve into BRMS1's functionality, explore its protein partners, and potentially advance research in cancer metastasis and therapeutic interventions. Elevate your research in metastasis suppression and tumor microenvironment with this precision antibody.
Product Name
BRMS1 antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
BACKGROUND
Transcriptional repressor. Down-regulates transcription activation by NF-kappa-B by promoting the deacetylation of RELA at 'Lys-310'. Promotes HDAC1 binding to promoter regions. Down-regulates expression of anti-apoptotic genes that are controlled by NF-kappa-B. Promotes apoptosis in cells that have inadequate adherence to a substrate, a process called anoikis, and may thereby inhibit metastasis. May be a mediator of metastasis suppression in breast carcinoma.
IMMUNOGEN INFORMATION
Immunogen
breast cancer metastasis suppressor 1
Observed MW
28 kDa
APPLICATION
Tested Application
ELISA, WB
Recommended Dilution
WB: 1:500-1:2000
UNIPROT INFORMATION
UniProt ID
IMAGES

Share
